American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 7(52), p. 2644-2646, 2008
DOI: 10.1128/aac.01618-07
Full text: Download
ABSTRACT Mycophenolic acid (MPA) is used clinically to prevent graft rejection but may increase the risk of fungal infection. We observed that MPA enhanced the Aspergillus fumigatus -induced oxidative burst of polymorphonuclear neutrophils, but without a corresponding increase in fungal killing. Furthermore, MPA inhibited the proinflammatory cytokine response and maturation of dendritic cells.